deferoxamine has been researched along with Infections, Yersinia in 46 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We describe a case of this unusual condition in a 17-year-old male patient with thalassemia intermedia requiring transfusion, who was also taking deferoxamine." | 3.68 | Yersinia enterocolitica infection with ileal perforation associated with iron overload and deferoxamine therapy. ( deSa, D; Gately, J; Mazzoleni, G; Riddell, RH, 1991) |
| " The severe toxic effects on vision, hearing and growth are all more likely at higher doses of DF and there appears to be partial protection against them by iron overload." | 2.38 | The toxic effects of desferrioxamine. ( Huehns, ER; Porter, JB, 1989) |
| "Our patient's unusual presentation of intussusception was secondary to the mass effect caused by lymphoid hyperplasia, specifically hypertrophied Peyer's patches in the ileum caused by Y enterocolitica infection." | 1.31 | Intussusception due to Yersinia enterocolitica enterocolitis in a patient with beta-thalassemia. ( Hansen, MG; Levy, M; Pearl, G, 2001) |
| "Deferoxamine therapy was withheld, and antibiotic therapy was administered with subsequent clinical improvement." | 1.29 | Yersinia enterocolitica infection in a patient with sickle cell disease after exposure to chitterlings. ( Casella, JF; Nataro, JP; Stoddard, JJ; Wechsler, DS, 1994) |
| "Systemic yersiniosis was further confirmed by the finding of antibodies to Yersinia enterocolitica O5." | 1.29 | [Hepatic abscess due to Yersinia in a child with thalassemia]. ( Brunel, F; Croize, J; Durand, C; François, P; Jeannoel, P, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (54.35) | 18.7374 |
| 1990's | 15 (32.61) | 18.2507 |
| 2000's | 6 (13.04) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greco, L | 1 |
| Marino, F | 1 |
| Gentile, A | 1 |
| Catalano, G | 1 |
| Angilletta, D | 1 |
| Robins-Browne, RM | 4 |
| Prpic, JK | 4 |
| Gordts, B | 1 |
| Rummens, E | 1 |
| deMeirleir, L | 1 |
| Butzler, JP | 1 |
| Scharnetzky, M | 1 |
| König, R | 1 |
| Lakomek, M | 1 |
| Tillmann, W | 1 |
| Schröter, W | 1 |
| Paitel, JF | 1 |
| Guerci, AP | 1 |
| Dorvaux, V | 1 |
| Lederlin, P | 1 |
| Chambers, CE | 1 |
| Sokol, PA | 1 |
| Autenrieth, IB | 2 |
| Reissbrodt, R | 1 |
| Saken, E | 1 |
| Berner, R | 1 |
| Vogel, U | 1 |
| Rabsch, W | 1 |
| Heesemann, J | 1 |
| Stoddard, JJ | 1 |
| Wechsler, DS | 1 |
| Nataro, JP | 1 |
| Casella, JF | 1 |
| Chandler, ND | 1 |
| Parisi, MT | 1 |
| Blei, F | 1 |
| Puder, DR | 1 |
| Brunel, F | 1 |
| François, P | 1 |
| Durand, C | 1 |
| Croize, J | 1 |
| Jeannoel, P | 1 |
| Adamkiewicz, TV | 1 |
| Berkovitch, M | 1 |
| Krishnan, C | 1 |
| Polsinelli, C | 1 |
| Kermack, D | 1 |
| Olivieri, NF | 1 |
| Sparling, PF | 1 |
| Schubert, S | 1 |
| Pallister, C | 1 |
| Rotstein, OD | 1 |
| Nikolova, S | 1 |
| Wesselinova, D | 1 |
| Vesselinova, A | 1 |
| Hansen, MG | 1 |
| Pearl, G | 1 |
| Levy, M | 1 |
| Lesic, B | 1 |
| Foulon, J | 1 |
| Carniel, E | 1 |
| de los Toyos, JR | 1 |
| Menéndez, P | 1 |
| Sampedro, A | 1 |
| Hardisson, C | 1 |
| Hoen, B | 2 |
| Kessler, M | 2 |
| Cabanne, JF | 1 |
| Dubot, P | 1 |
| Mazzoleni, G | 1 |
| deSa, D | 1 |
| Gately, J | 1 |
| Riddell, RH | 1 |
| Abcarian, PW | 1 |
| Demas, BE | 1 |
| Pierron, H | 1 |
| Gillet, R | 1 |
| Perrimond, H | 1 |
| Broudeur, JC | 1 |
| Soudry, G | 1 |
| Porter, JB | 1 |
| Huehns, ER | 1 |
| Freedman, MH | 2 |
| Bentur, Y | 1 |
| Koren, G | 1 |
| Hughes, RT | 1 |
| Keidan, J | 1 |
| Janmohamed, R | 1 |
| Leyland, MJ | 1 |
| Chiu, HY | 1 |
| Flynn, DM | 1 |
| Hoffbrand, AV | 1 |
| Politis, D | 1 |
| Kelly, D | 1 |
| Price, E | 1 |
| Wright, V | 1 |
| Walker-Smith, J | 1 |
| Rossiter, M | 1 |
| Warren, JJ | 1 |
| Waterlot, Y | 1 |
| Vanherweghem, JL | 2 |
| Dumont-Senaneuch, C | 1 |
| Floret, D | 1 |
| Philippe, N | 1 |
| Masters, AP | 1 |
| Hopkinson, RB | 1 |
| Renoult, E | 1 |
| Jonon, B | 1 |
| Stuart, SJ | 1 |
| Hadjiminas, JM | 1 |
| Eggleston, SM | 1 |
| Huang, CB | 1 |
| Löhr, H | 1 |
| Mofenson, HC | 1 |
| Caraccio, TR | 1 |
| Sharieff, N | 1 |
| Chiesa, C | 1 |
| Pacifico, L | 1 |
| Renzulli, F | 1 |
| Midulla, M | 1 |
| Garlaschi, L | 1 |
| Boelaert, JR | 2 |
| van Landuyt, HW | 1 |
| Valcke, YJ | 1 |
| Cantinieaux, B | 1 |
| Lornoy, WF | 1 |
| Moreillon, P | 1 |
| Vandepitte, JM | 2 |
| Vergauwe, PL | 1 |
| Gallant, T | 1 |
| Vellend, H | 1 |
| Francombe, WH | 1 |
| Boyce, N | 1 |
| Wood, C | 1 |
| Holdsworth, S | 1 |
| Thomson, NM | 1 |
| Atkins, RC | 1 |
| Davey, RB | 1 |
4 reviews available for deferoxamine and Infections, Yersinia
| Article | Year |
|---|---|
Yersinia enterocolitica bacteremia in a chronically transfused patient with sickle cell anemia. Case report and review of the literature.
Topics: Adolescent; Anemia, Sickle Cell; Bacteremia; Blood Transfusion; Ceftriaxone; Deferoxamine; Disease S | 1993 |
The toxic effects of desferrioxamine.
Topics: Animals; Blood-Brain Barrier; Deferoxamine; Disease Susceptibility; Eye Diseases; Growth Disorders; | 1989 |
Biological and toxic properties of deferoxamine.
Topics: Cataract; Cell Division; Deferoxamine; DNA; Drug Hypersensitivity; Hearing Disorders; Humans; Pulmon | 1989 |
Yersiniae and iron. A study in host-parasite relationships.
Topics: Deferoxamine; Humans; Iron; Siderosis; Virulence; Yersinia; Yersinia Infections | 1987 |
1 trial available for deferoxamine and Infections, Yersinia
| Article | Year |
|---|---|
[Infectious risks in patients with renal failure on hemodialysis. Importance of iron overload and deferoxamine].
Topics: Bacterial Infections; Deferoxamine; Ferritins; Humans; Incidence; Iron; Kidney Failure, Chronic; Lis | 1991 |
41 other studies available for deferoxamine and Infections, Yersinia
| Article | Year |
|---|---|
Yersinia enterocolitica ileocolitis in beta-thalassemic patients.
Topics: Adult; Appendectomy; beta-Thalassemia; Comorbidity; Crohn Disease; Deferoxamine; Female; Humans; Mal | 2006 |
Desferrioxamine and systemic yersiniosis.
Topics: Animals; Deferoxamine; Humans; Iron; Mice; Thalassemia; Yersinia enterocolitica; Yersinia Infections | 1983 |
Yersinia pseudotuberculosis septicaemia in thalassaemia major.
Topics: Adolescent; Deferoxamine; Female; Humans; Sepsis; Thalassemia; Yersinia Infections; Yersinia pseudot | 1984 |
Prophylaxis of systemic yersinosis in thalassaemia major.
Topics: Child; Deferoxamine; Female; Humans; Risk; Sepsis; Thalassemia; Yersinia Infections | 1984 |
[Yersinia enterocolitica septicemia, iron overload and deferoxamine].
Topics: Anemia, Sideroblastic; Bacteremia; Cephalosporins; Deferoxamine; Humans; Iron; Male; Middle Aged; Ye | 1995 |
Comparison of siderophore production and utilization in pathogenic and environmental isolates of Yersinia enterocolitica.
Topics: Animals; Bacterial Outer Membrane Proteins; Deferoxamine; Environmental Microbiology; Ferric Compoun | 1994 |
Desferrioxamine-promoted virulence of Yersinia enterocolitica in mice depends on both desferrioxamine type and mouse strain.
Topics: Animals; Cell Division; Deferoxamine; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, | 1994 |
Yersinia enterocolitica infection in a patient with sickle cell disease after exposure to chitterlings.
Topics: Anemia, Sickle Cell; Animals; Child; Deferoxamine; Female; Food Microbiology; Humans; Intestines; Sw | 1994 |
Radiological case of the month. Yersinia enterocolitica masquerading as appendicitis.
Topics: Abscess; Appendicitis; beta-Thalassemia; Biopsy; Child; Deferoxamine; Diagnosis, Differential; Hemog | 1994 |
[Hepatic abscess due to Yersinia in a child with thalassemia].
Topics: Adolescent; beta-Thalassemia; Deferoxamine; Humans; Iron; Liver Abscess; Male; Yersinia enterocoliti | 1993 |
Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: incidence and predisposing factors.
Topics: Adolescent; Adult; beta-Thalassemia; Canada; Causality; Chelating Agents; Child; Child, Preschool; C | 1998 |
Iron and infection.
Topics: beta-Thalassemia; Canada; Causality; Chelating Agents; Deferoxamine; Humans; Incidence; Yersinia ent | 1998 |
Conjugation of hydroxyethyl starch to desferrioxamine (DFO) modulates the dual role of DFO in Yersinia enterocolitica infection.
Topics: Animals; Cell Division; Chelating Agents; Deferoxamine; Drug Compounding; Hydroxyethyl Starch Deriva | 2000 |
Yersinia enterocolitica as a cause of intra-abdominal abscess: the role of iron.
Topics: Abdominal Abscess; Abdominal Pain; Adult; Anti-Bacterial Agents; beta-Thalassemia; Chelating Agents; | 2001 |
Pretreatment of guinea-pigs with iron or desferal influences the course of Yersinia enterocolitica infections.
Topics: Administration, Oral; Animals; Antigens, Bacterial; Chelating Agents; Deferoxamine; Electrophoresis, | 2001 |
Intussusception due to Yersinia enterocolitica enterocolitis in a patient with beta-thalassemia.
Topics: beta-Thalassemia; Child, Preschool; Deferoxamine; Enterocolitis; Humans; Hypertrophy; Ileum; Intussu | 2001 |
Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica.
Topics: 2,2'-Dipyridyl; Animals; Chelating Agents; Culture Media; Deferiprone; Deferoxamine; Iron Chelating | 2002 |
Yersinia enterocolitica serotype 0:3-induced arthritis in mice: microbiological and histopathological information.
Topics: Animals; Arthritis, Infectious; Bone Marrow; Cartilage, Articular; Deferoxamine; Disease Models, Ani | 1992 |
[Severe Yersinia enterocolitica infections in kidney failure patients under dialysis].
Topics: Adolescent; Adult; Deferoxamine; Female; Humans; Immune Tolerance; Iron; Kidney Failure, Chronic; Ma | 1991 |
Yersinia enterocolitica infection with ileal perforation associated with iron overload and deferoxamine therapy.
Topics: Adolescent; Blood Transfusion; Deferoxamine; Humans; Ileal Diseases; Intestinal Perforation; Iron; L | 1991 |
Systemic Yersinia enterocolitica infection associated with iron overload and deferoxamine therapy.
Topics: Blood Transfusion; Child, Preschool; Deferoxamine; Gastroenteritis; Humans; Male; Mesenteric Lymphad | 1991 |
[Yersinia infection and hemoglobin disorder. Apropos of 4 cases].
Topics: Anemia, Sickle Cell; Child; Deferoxamine; Female; Humans; Iron; Male; Thalassemia; Yersinia enteroco | 1990 |
Yersinia and iron.
Topics: Adult; Deferoxamine; Female; Humans; Iron; Yersinia; Yersinia Infections | 1987 |
Infection with Yersinia enterocolitica in patients with iron overload.
Topics: Adult; Anemia, Sideroblastic; Blood Transfusion; Deferoxamine; Female; Hemosiderosis; Humans; Male; | 1986 |
Yersinia and iron overload.
Topics: Deferoxamine; Female; Humans; Infant; Thalassemia; Yersinia enterocolitica; Yersinia Infections | 1986 |
Why deferoxamine therapy predisposes to Yersinia sepsis.
Topics: Deferoxamine; Humans; Yersinia Infections | 1987 |
[Desferrioxamine in hemodialysis as the cause of Yersinia enterocolitica septicemia].
Topics: Deferoxamine; Female; Humans; Middle Aged; Renal Dialysis; Yersinia enterocolitica; Yersinia Infecti | 1985 |
[Fatal Yersinia enterocolitica septic shock in a child with chronic anemia].
Topics: Anemia, Hemolytic, Congenital; Child, Preschool; Deferoxamine; Humans; Male; Risk Factors; Shock, Se | 1988 |
Yersinia enterocolitica septicaemia.
Topics: Adult; Deferoxamine; Hemosiderosis; Humans; Sepsis; Thalassemia; Yersinia enterocolitica; Yersinia I | 1988 |
Septicemia due to Yersinia enterocolitica in a long-term hemodialysis patient after a single desferrioxamine administration.
Topics: Deferoxamine; Humans; Male; Middle Aged; Renal Dialysis; Sepsis; Yersinia enterocolitica; Yersinia I | 1988 |
Yersiniosis in acutely iron-loaded children treated with desferrioxamine.
Topics: Child; Deferoxamine; Humans; Infant; Iron; Sepsis; Yersinia Infections | 1988 |
Comment: deferoxamine-induced sepsis.
Topics: Deferoxamine; Humans; Yersinia Infections | 1987 |
[Yersinia septicemia in children with thalassaemia major].
Topics: Child; Child, Preschool; Deferoxamine; Female; Hemosiderosis; Humans; Male; Risk Factors; Sepsis; Th | 1987 |
Iron sepsis: Yersinia enterocolitica septicemia possibly caused by an overdose of iron.
Topics: Acute Disease; Deferoxamine; Diseases in Twins; Female; Humans; Infant; Iron; Male; Sepsis; Yersinia | 1987 |
Yersinia hepatic abscesses and iron overload.
Topics: Child; Child, Preschool; Deferoxamine; Female; Humans; Iron; Male; Thalassemia; Yersinia enterocolit | 1987 |
The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients.
Topics: Adult; Aged; Deferoxamine; Female; Ferritins; Humans; Iron; Male; Middle Aged; Renal Dialysis; Sepsi | 1987 |
Mucormycosis infection in dialysis patients.
Topics: Deferoxamine; Humans; Iron; Mucormycosis; Renal Dialysis; Yersinia Infections | 1987 |
Yersinia sepsis in patients with iron overload treated with deferoxamine.
Topics: Adult; Deferoxamine; Female; Humans; Iron; Thalassemia; Yersinia enterocolitica; Yersinia Infections | 1986 |
Life-threatening sepsis complicating heavy metal chelation therapy with desferrioxamine.
Topics: Adult; Deferoxamine; Humans; Iron; Male; Renal Dialysis; Sepsis; Yersinia Infections | 1985 |
Effects of iron and desferrioxamine on infections with Yersinia enterocolitica.
Topics: Animals; Deferoxamine; Dose-Response Relationship, Drug; Guinea Pigs; Iron; Mice; Transferrin; Yersi | 1985 |
In vitro assessment of virulence in Yersinia enterocolitica and related species.
Topics: Agglutination Tests; Animals; Blood Bactericidal Activity; Calcium; Congo Red; Deferoxamine; Iron-De | 1985 |